Vehicle Safety
Recalls Search 320,000+ NHTSA safety recalls Complaints 2.1M+ consumer safety complaints TSBs 4.7M technical service bulletins VIN Lookup Decode any vehicle VIN instantly OBD Codes 12,000+ diagnostic trouble codes Fuel Economy EPA MPG data for all vehicles Safety Ratings 11,700+ NHTSA crash test ratings Investigations 5,300+ NHTSA defect investigations Statistics Recall trends & safety analysis
Consumer Safety
Product Safety 9,700+ CPSC product recalls Food Safety 28,600+ FDA food recalls Pet Safety 1.3M FDA animal adverse events Drug Safety 17,500+ FDA drug recalls Device Safety 38,400+ FDA device recalls Workplace Safety 102,900+ OSHA injury reports Brand History Cross-category recall lookup by company
Infrastructure
Bridge Safety 624,000 bridge inspections Aviation Safety 30,000+ NTSB aviation events Dam Safety 92,600 dam safety records Water Safety 433,000+ public water systems Railroad Safety 438,000+ rail crossings Pipeline Safety 8,800+ pipeline incidents
Public Health
Nursing Homes 14,700 CMS rated facilities Environmental 80,000+ hazardous sites & releases

Browse Drug Recalls

116 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 116 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 116 FDA drug recalls.

Clear
DateProductReasonClassFirm
Apr 6, 2016 Lisinopril Tablets USP, 40 mg, 1000-count bottles, Rx only, Manufactured for:... CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose int... Class III Lupin Pharmaceuticals Inc.
Apr 4, 2016 Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg, packaged in a)100-c... CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose int... Class III Lupin Pharmaceuticals Inc.
Mar 24, 2016 Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for:... Labeling: Incorrect or Missing Lot and/or Expiration Date Class III Lupin Limited
Mar 11, 2016 Ceftriaxone for Injection USP, 250 mg, Single Use Vial, packaged in a) 1-coun... CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose int... Class III Lupin Pharmaceuticals Inc.
Mar 11, 2016 Ceftriaxone Sodium (Sterile) USP active pharmaceutical ingredient, DMF No. 15... CGMP Deviations: active pharmaceutical ingredient intermediates failed specifications. Class III Lupin Pharmaceuticals Inc.
Mar 11, 2016 Ceftriaxone for Injection USP, 1 g, Single Use Vial (NDC 68180-633-01) packag... CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose int... Class III Lupin Pharmaceuticals Inc.
Mar 11, 2016 Ceftriaxone for Injection USP, 500 mg, Single Use Vial, packaged in a) 1-coun... CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose int... Class III Lupin Pharmaceuticals Inc.
Mar 11, 2016 Ceftriaxone for Injection USP, 2 g, Single Use Vial (NDC 68180-644-01) packag... CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose int... Class III Lupin Pharmaceuticals Inc.
Feb 19, 2016 Amlodipine Besylate Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactu... CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose int... Class III Lupin Limited
Feb 19, 2016 Amlodipine Besylate Tablets USP, 2.5mg, 90-count bottles, Rx only, Manufactur... CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose int... Class III Lupin Limited
Jan 27, 2014 Suprax, Cefixime for Oral Suspension USP 500 mg/5 ml, 10mL (when reconstitute... Failed Impurities/Degradation Specifications: Product did not meet specification in total impurit... Class III Lupin Pharmaceuticals Inc.
Jan 27, 2014 Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstit... Failed Impurities/Degradation Specifications: Product did not meet specification in total impurit... Class III Lupin Pharmaceuticals Inc.
Sep 17, 2013 Quinapril Tablets USP, 5 mg, 90 count bottle, Rx only, Manufactured for: Lup... Failed Impurities/Degradation Specifications: During stability testing an unknown impurity was fo... Class II Lupin Pharmaceuticals Inc.
Sep 17, 2013 Quinapril Tablets USP, 10 mg, 90 count bottle, Rx only, Manufactured for: Lu... Failed Impurities/Degradation Specifications: During stability testing an unknown impurity was fo... Class II Lupin Pharmaceuticals Inc.
Feb 22, 2013 Ethambutol Hydrochloride Tablets USP, 400 mg, 100-count bottles, Rx only, Man... Failed Impurities/Degradation Specifications: This product is being recalled due to an out of spe... Class III Lupin Pharmaceuticals Inc.
Jan 31, 2013 Suprax (cefixime for oral suspension) USP, 100 mg/5 mL, 50 mL bottles (when r... Discoloration; Product may not meet specifications for color description once reconstituted. Class III Lupin Pharmaceuticals Inc.

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.